Gastrointestinal Sarcoidosis - PowerPoint PPT Presentation

1 / 18
About This Presentation
Title:

Gastrointestinal Sarcoidosis

Description:

Gastrointestinal Sarcoidosis Katherine Doktor, MD PGY-2 The Patient 52yoF, AA p/w exacerbation of chronic N/V/abd pain, a/f decreased PO intake PMHx: HTN, DM ... – PowerPoint PPT presentation

Number of Views:145
Avg rating:3.0/5.0
Slides: 19
Provided by: Katherine199
Category:

less

Transcript and Presenter's Notes

Title: Gastrointestinal Sarcoidosis


1
Gastrointestinal Sarcoidosis
  • Katherine Doktor, MD
  • PGY-2

2
The Patient
  • 52yoF, AA p/w exacerbation of chronic N/V/abd
    pain, a/f decreased PO intake
  • PMHx HTN, DM, sarcoidosis, chronic pancreatitis,
    evidence of carcinoid in duodenum, ?autoimmune
    hepatitis dxd 10yrs ago
  • PSurgHx removal of sarcoid nodule on dorsum of L
    hand, s/p Whipple J-tube placement April 10
  • Dx of Sarcoidosis in Sept 09 by needle Bx of
    medistinal node skin mass on hand

3
The Patients Workup
  • Labs
  • CA 19-9
  • Alk phos
  • ERCP x2 (Feb March 10) findings c/w
    pancreatic divisum, chronic pancreatitis
    demonstrated pancreatic mass in head
  • Gastric emptying scan delayed gastric emptying
    in March, but not during this admission
  • s/p Whipple (4/10) surgical management bc of
    pts nutritional decline, presence on pancreatic
    head mass and elevated CA 19-9
  • Obstruction series no evidence of obstructing
    lesions

4
Sarcoidosis
  • First described by Hutchinson in 18773
  • Non-caseating granulomas
  • Multisystem disease lungs, skin, cardiac,
    neurologic, LN
  • Frequency of organ involvement lung (90) gt LN
    (75) gt liver (60-90)
  • GI involvement gastric 2.5, intestinal 3.4
  • Age group 20-40s
  • Prevalence 1-40/100,000
  • At least 3x higher in AA than Caucasians
  • Main cause of death due to involvement of lungs
    and heart

5
Sarcoidosis Making the Diagnosis
  • History
  • Demonstration of granulomas in two different
    organs
  • Rule-out drug-induced disease

6
Organ involvement
  • Liver most common
  • Hollow organs stomach, small bowel, colon
  • Pancreas
  • 1st described in 1937

7
Sarcoidosis of the Liver
  • Involvement seen in 50-79 of pts by Bx and
    67-70 by autopsy
  • Pts w/ fever /or arthralgias or extensive
    erythema nodosum tend to have abnl liver Bx
  • Sx pruritis abd pain gt jaundice
  • DDx of hepatic granulomas
  • sarcoidosis
  • Drug-induced disease
  • Underlying liver disease (esp PBC)
  • TB

8
Sarcoidosis of the Liver the work-up
  • Liver enzymes elevated in up to 35, unrelated
    to degree or extent of disease
  • Elevated Alk phos is more reliable than GGT in
    predicting liver involvement
  • US parenchymal echogenicity, coarsening of the
    liver parenchyma w/or w/o discrete nodules, and
    focal calcifications as well as contour
    irregularity
  • CT HSM, adenopathy, particularly of the porta
    hepatis, paraaortic region and celiac axis,
    followed in frequency by low-attenuation lesions
    of the liver and spleen
  • MRI multiple, diffuse, densely packed, uniform
    nodular foci w/nml to slightly increased signal
    intensity. T2-weighted images show decreased
    signal intensity

9
Sarcoidosis of the Liver
  • Granulomas
  • 24-94 of liver Bx autopsies
  • Granulomas classic sarcoid granulmas mainly
    found in portal triads w/a cluster of lg
    epithelioid cells, often w/ multinucleated giant
    cells.
  • Schaumann bodies rarely seen in hepatic
    granulomas
  • Granluomas may be of differing ages
  • Progressive Liver disease

10
Sarcoidosis of the Stomach
  • Most common in antrum
  • Sx most common is postprandial epigastric pain
    (dull, burning or cramping) also N/V, heartburn,
    early satiety and weight loss (common, can be
    severe), occ UGIB
  • Manifestations due to ulcers or lumen narrowing
    2/2 fibrosis
  • Endoscopy nodular changes, gastritis, thickened
    mucosa, greater or lesser curvature deformities
    or benign or malignant-appearing ulcers
  • UGI series most commonly shows segmental mucosal
    thickening nondistensibility (mimicking linitis
    plastica) /or deformities in antrum

11
Sarcoidosis of the Bowel
  • Small bowel least commonly involved organ in GI
    sarcoidosis
  • Presentation diarrhea, malabsorption,
    protein-losing enteropathy, periumbilical or
    epigastric pain or hemorrhage
  • Colon multiple nodules, polyps, stenosis,
    obstructive lesions, aphthous erosions, or small
    punctate bleeding sites
  • Over 50 pts have abd pain
  • Most common cause of intestinal obstruction
    external compression by LAN

12
Sarcoidosis of the Pancreas
  • Sx rare assocd w/parenchymal disease or duct
    obstruction
  • abd pain, wt loss, jaundice, nausea, anorexia
  • the findings may simulate carcinoma w/pain
    improving w/corticosteroids
  • Findings
  • a mass, usually in the head or
  • a diffusely firm, nodular pancreas

13
Sarcoidosis of the Pancreasthe workup
  • Labs chronically elevated lipase/amylase
  • MRI masses w/low signal intensity on
    T1-weighted images, mild high signal intensity on
    T2-weighted images, and reduced enhancement
    w/gadolinium
  • Endoscopic US glandular fibrosis
  • Results of corticosteroid Tx decreased
    lipase/amylase, reduced size of liver spleen,
    but no improvement in fibrosis

14
Additional Involvement of Sarcoidosis with the GI
Tract
  • Acute cholecystitis
  • Obstructive jaundice
  • Abdominal adenopathy
  • Increased in number of normal-sized nodes
  • Most common in the porta hepatis
  • LN smaller and more discrete than in lymphoma
  • IFN-a therapy for Hepatitis C

15
Treatment of GI Sarcoidosis
  • Partial response to PPI and antacids
  • Corticosteroids
  • Start when organ function is threatened
  • 66 of people show improvement in Sx
  • Hepatic sarcoid
  • Tx only symptomatic pts
  • Only minimal effect on hepatic lesions
  • Reduces liver size number of granulomas
  • No effect on portal HTN
  • No improvement seen in cases involving chronic
    intrahepatic cholestasis
  • Some improvement in LFTs in cases of mild-mod
    elevation, but no significant improvement in
    severe elevation

16
Treatment Steroid-sparing Agents
  • Methotrexate
  • Shown to be effective in an RCT
  • 10 pts have toxic rxns
  • Others chloroquine, azathioprine and
    cyclophosphamide
  • Infliximab
  • Ursodeoxycholic acid

17
REFERENCES
  • Ebert EC, Kierson, KD Hagspiel. Gastrointestinal
    and Hepatic Manifestations of Sarcoidosis. Am J
    Gastroenterol 2008 1033184-3192.
  • Sharma OP. Gastrointestinal sarcoidosis. In
    UpToDate, Hollingsworth, H (DE), UpToDate,
    Waltham, MA 2010.
  • 3 caceres m, sabbaghian s, braud r, wilks s, b
    michael. Pancreatic sarcoidosis Unusual
    Presentation Resembling a Periampullary
    Malignancy. Curr Surg, 63 (2006)179-185.

18
DDx of granulomas
  • Sarcoidosis
  • Drug-induced disease
  • Underlying liver disease (esp PBC)
  • TB
  • Whipples dz
  • Crohns dz
  • Syphilis
  • Fungal infections
  • Foreign body rxn
Write a Comment
User Comments (0)
About PowerShow.com